Skip to main content

DID FABIFLU IS THE MEDICINE OF COVID-19 ?

Fabiflu in COVID-19 

As we know the vaccine is still a long distance away and no sign of the coronavirus infections slowing down in the country , homegrown pharmaceutical companies have been given permission to launch generic versions of Remdesivir and Favipiravir , anti-viral drugs that have shown promise in treating Covid-19 patients.


Glenmark pharmaceuticles has launched favipiravir under the brand name FabiFlu for treatment of mild to moderate cases of Covid-19 , cipla and hetero labs have received approvals from the Drug Controller General of India to launch generic versions of Remedesivir under the names Cipremi and Covifor respectively.

While medical experts have cautioned against seeing these potential drugs as a "magic bullet" against the deadly virus , they can be helpful in reducing the viral load as India continues to post new record highs in infection on a daily basis.

Remedesivir and Favipiravir are two of the 130 under experimentation drugs worldwide to treat covid-19.

Covifor and Cipremi are the two drugs launched by Cipla and Hetero are generic versions of Remedesivir , an antiviral drug first developed for treating Ebola in 2014.
it is administered intravenously and inhibits viral replication in the body.

Last month , the US National Institutes of Allergies and Infectious Diseases had released preliminary trial results showing recovery time of Covid-19 patients given Remedesivir improved from 15 to 11 days.

The Health ministry had approved the use of Remedesivir for mild cases of Covid-19 through an emergency authorisation route.

Since Remedesivir has not been approved as treatment for Covid-19 yet and has been approved by the DCGI only for restricted emergency use , a patient would need to sign a consent form in case it is administered .
It is not recommended for those with severe renal impairment and high level of liver enzymes , pregnant and lactating women , and those below 12 years.

FABIFLU will be manufactured by Mumbai based Glenmark Pharmaceuticals as the genric version of Favipiravir , an anti viral drug approved in Japan for treating influenza.
The oral medicine is approved only for emergency restricted use in mild to moderate Covid-19 cases.
The approvals restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

It is currently being tested in 18 clinical trials for Covid-19 and results from two studies have shown positive outcome , while data from othre trials is awaited.

Glenmark has claimed that Favipiravir shows clinical improvements of up to 88 percent in Covid-19 with rapid reduction in viral load by four days.

The drug will be available as a precription based medication for Rs 103/tablet , with recommended dose being 1800 mg twice daily on day 1 , followed by 800 mg twice daily up to day 14.
Labels:

Comments

Post a Comment

If you have any doubt. Let me know

Popular posts from this blog

Possible Causes of Hand Pain

The human hands are complex and delicate structures that contain 27 bones. The muscles and joints in the hand allow for strong , precise and dexterous movements , but they are vulnerable to injury. There are many different causes and types of hand pain. Hand pain can originate in different parts of the complex skeletal structure , including the : bones joints connective tissue tendons nerves Hand  pain can stem from: inflammation nerve damage repetitive motion injuries sprains and fractures several chronic health conditions Many conditions contributing to hand pain can be treated. Depending on the cause of your hand pain, you may benefit from medications , exercises or lifestyle changes. 1. ARTHRITIS Arthritis (the inflammation of one or more joints) is the leading cause of hand pain. It can occur anywhere in the body but is particularly common in hands and wrist. There are more than 100 different types  of arthritis, but the most common are osteoarthritis and rheumatoid arthr...
Post a Comment
Read more

OBSESSIVE COMPULSIVE DISORDER(OCD)

Anxiety Disorder: WHAT IS OCD? Obsessive - compulsive disorder (OCD) is an anxiety disorder in which time people have recurring , unwanted thoughts , ideas or sensations that make them feel driven to do something repetitively. OCD causes the brain to get stuck on a particular thought or urge. For example: You may check the stove 20 times to make sure it's really turned off because you are terrified of burning down your house. Or , you may wash your hands until they are scrubbed raw for fear of germs. OCD OBSESSION AND COMPULSION: Obsession are involuntary thoughts , images or impulses that occur over and over again in your mind. These obsessive thoughts are often disturbing and distracting. Compulsions are behaviors that you feel driven to act out again and again. For eg: If you afraid of contamination , you might develop elaborate cleaning rituals , However the relief never lasts. THE VICIOUS CYCLE OF OCD : Mostly people with OCD fall int...
Post a Comment
Read more

Caring for Someone Having COVID - 19

  How to care for Someone having COVID-19 (Home Isolation) 1. Provide Support : Help the patient in covering their basic needs.  Make sure the patient will drink more fluids and take rest. See if the over counter medicines for fever help the person or not. watch the warning signs i.e Oxygen level  2. Protect yourself : Keep a separate bedroom and bathroom for a person who is sick. As this virus spread between people who are in close contact through respiratory droplets , coughs or sneezes .  Avoid having visitors. Caregivers should also quarantine themselves. Eat in separate areas or rooms. Avoid sharing personal items : Do not share dishes, bedding , or cell phone with the person suffering. When to wear a MASK ? When there is people around at home. Mask helps prevent a person who is sick from spreading the virus to others. Caregiver will always wear a mask before entering the room of the sufferer. Wash Hands : Wash your hands often with soap and water especially aft...
Post a Comment
Read more